Thoden; James B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thoden; James B..The latest application filed is for "crystallization of (20r) and (20s) analogs of 2-methylene-19-nor-24-dimethyl-1alpha,25-dihydroxyvitamin d3".

Company Profile

0.12.12

Thoden; James B. - Madison WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1.alpha.,25-dihydroxyvitamin D.sub.3 and related precursors Grant 9,212,137 - DeLuca , et al. December 15, 2	2015-12-15
Crystallization of (20R) 19-nor-24-difluoro-1.alpha.,25-dihydroxyvitamin D.sub.3 Grant 9,040,728 - DeLuca , et al. May 26, 2	2015-05-26
Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1.alpha.,25-dihydroxyvitamin D3 Grant 8,940,916 - DeLuca , et al. January 27, 2	2015-01-27
Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1.alpha.,25-dihydroxyvitamin D.sub.3 Grant 8,884,039 - DeLuca , et al. November 11, 2	2014-11-11
Diastereomers of 2-methylene-19-nor-22-methyl-1.alpha.,25-dihydroxyvitamin D.sub.3 Grant 8,664,206 - DeLuca , et al. March 4, 2	2014-03-04
Crystallization of (20R) 19-Nor-24-Difluoro-1alpha,25-Dihydroxyvitamin D3 App 20130324751 - DeLuca; Hector F. ; et al.	2013-12-05
Crystallization of (20R,22R)-2-Methylene-19-Nor-22-Methyl-1alpha,25-Dihydroxyvitamin D3 and Related Precursors App 20130324752 - DeLuca; Hector F. ; et al.	2013-12-05
Crystallization of (20R)-2-Methylene-19-Nor-24-Difluoro-1alpha,25-Dihydroxyvitamin D3 App 20130324750 - DeLuca; Hector F. ; et al.	2013-12-05
Crystallization of (20R) and (20S) Analogs of 2-Methylene-19-Nor-24-Dimethyl-1alpha,25-Dihydroxyvitamin D3 App 20130324749 - DeLuca; Hector F. ; et al.	2013-12-05
Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3 Grant 8,519,169 - DeLuca , et al. August 27, 2	2013-08-27
Crystallization of 1.alpha.-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol Grant 8,420,839 - DeLuca , et al. April 16, 2	2013-04-16
Crystallization of 1alpha-Hydroxy-2-Methylene-18,19-Dinor-Homopregnacalciferol App 20130090486 - DeLuca; Hector F. ; et al.	2013-04-11
(20R,25S)-2-Methylene-19,26-Dinor-1.alpha.,25-Dihydroxyvitamin D.sub.3 in crystalline form Grant 8,404,874 - DeLuca , et al. March 26, 2	2013-03-26
Crystallization of 1alpha-Hydroxy-20-Methyl-2-Methylene-19,24,25,26,27-Pentanorvitamin D3 App 20130053587 - DeLuca; Hector F. ; et al.	2013-02-28
Diastereomers Of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin D3 App 20120165300 - DeLUCA; Hector F. ; et al.	2012-06-28
(20R,25S)-2-Methylene-19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 in Crystalline Form App 20120083614 - DeLuca; Hector F. ; et al.	2012-04-05
Diastereomers Of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin D3 App 20110237557 - DeLuca; Hector F. ; et al.	2011-09-29
Mammalian cell lines specifically deficient in O-linked glycosylation App 20050112723 - Fridovich-Keil, Judith L. ; et al.	2005-05-26
2-methylene-19-nor-20(S)-1.alpha.-hydroxy-bis-homo-pregnacalciferol in crystalline form Grant 6,835,723 - DeLuca , et al. December 28, 2	2004-12-28
2-Methylene-19-nor-20(S)-1alpha-hydroxy-bis-homo-pregnacalciferol in crystalline form App 20030204103 - DeLuca, Hector F. ; et al.	2003-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.